Home › Funds › Kercheville Advisors, LLC › IBRX

Kercheville Advisors, LLC position in IBRX

IMMUNITYBIO INC · Health Care

Kercheville Advisors, LLC reported holding 613,385 shares of IBRX (IMMUNITYBIO INC) in its Q3 2026 13F filing — a position valued at US$5.8M, representing 1.60% of its reported portfolio and ranking #21 among its reported holdings. Kercheville Advisors, LLC has disclosed IBRX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)613.38K sh
Reported value held$5.79M
Portfolio Weight1.60%
First reportedQ2 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Kercheville Advisors, LLC's IBRX position evolved

Kercheville Advisors, LLC first disclosed a stake in IBRX in Q2 2025 at 100,500 shares (US$265K). The position peaked in Q3 2026 at 613,385 shares, worth US$5.8M. Across 6 filings, Kercheville Advisors, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 613,385 shares valued at US$5.8M — a reduction of -31,300 shares quarter over quarter.. Notable position changes include a 417% increase in Q3 2025 (shares fell 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 100.50K $265.32K New
Q3 2025 519.10K $1.28M Add
Q4 2025 584.17K $4.29M Add
Q1 2026 643.14K $4.93M Add
Q2 2026 644.68K $5.64M Hold
Q3 2026 613.38K $5.79M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBRX and 13F data

IBRX (IMMUNITYBIO INC) is a Health Care company. 68 other funds we track also report a position in IBRX — the largest reported positions include GREAT POINT PARTNERS LLC (US$26.3M), VESTOR CAPITAL, LLC (US$12.1M), Sound Capital Solutions LLC (US$9.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBRX

All IBRX fund holders →

FAQ

How long has Kercheville Advisors, LLC held IBRX?

Kercheville Advisors, LLC has disclosed IBRX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Kercheville Advisors, LLC's current position in IBRX?

As of Q3 2026, Kercheville Advisors, LLC holds 613.38K shares of IBRX (IMMUNITYBIO INC), valued at $5.79M, representing 1.60% of its reported portfolio and ranking #21.

Has Kercheville Advisors, LLC been buying or selling IBRX?

In the latest 13F filing (Q3 2026), Kercheville Advisors, LLC reduced its position in IBRX. The position peaked in Q3 2026 at 613.38K shares.

Which other funds hold IBRX?

Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, VESTOR CAPITAL, LLC, Sound Capital Solutions LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.